Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$856M |
| 2 |
Meta Platforms (Facebook)
META
|
+$647M |
| 3 |
NVIDIA
NVDA
|
+$615M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$304M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.03B |
| 2 |
UnitedHealth
UNH
|
+$686M |
| 3 |
Tesla
TSLA
|
+$387M |
| 4 |
Abbott
ABT
|
+$380M |
| 5 |
Chevron
CVX
|
+$328M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.26% |
| 2 | Healthcare | 16.96% |
| 3 | Consumer Discretionary | 12.82% |
| 4 | Consumer Staples | 9.14% |
| 5 | Industrials | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3401
EyePoint Inc
EYPT
$1.17B
| $134K | ﹤0.01% |
15,400
-55,900
| -78% | -$341K |
|
3402
ReWalk Robotics
LFWD
$21.8M
| $134K | ﹤0.01% |
2,649
+500
| +23% | +$26.1K |
|
|
BHIL
3403
DELISTED
Benson Hill, Inc.
BHIL
| $134K | ﹤0.01% |
2,940
-3,280
| -53% | -$140K |
|
|
LEJU
3404
DELISTED
Leju Holdings Limited American Depositary Shares, each representing ten (10) Ordinary Shares
LEJU
| $134K | ﹤0.01% |
58,199
-4,500
| -7% | -$9.73K |
|
3405
Clear Channel Outdoor Holdings
CCO
$1.23B
| $133K | ﹤0.01% |
97,092
-40,059
| -29% | -$49.9K |
|
|
CYAN
3406
DELISTED
Cyanotech Corp
CYAN
| $133K | ﹤0.01% |
154,509
-17,600
| -10% | -$17.6K |
|
|
DBTX
3407
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
| $132K | ﹤0.01% |
34,400
+1,900
| +6% | +$6.97K |
|
3408
Werewolf Therapeutics
HOWL
$18.6M
| $131K | ﹤0.01% |
42,900
+8,800
| +26% | +$24.8K |
|
3409
Tempest Therapeutics
TPST
$19.3M
| $131K | ﹤0.01% |
7,954
+5,916
| +290% | +$149K |
|
3410
Arts-Way Manufacturing Co
ARTW
$13.3M
| $130K | ﹤0.01% |
55,674
-7,900
| -12% | -$19.7K |
|
|
DFTX
3411
Definium Therapeutics
DFTX
$5.75B
| $130K | ﹤0.01% |
36,519
-19,267
| -35% | -$66.5K |
|
3412
FinWise Bancorp
FINW
$191M
| $128K | ﹤0.01% |
14,300
+600
| +4% | +$5.1K |
|
3413
Ocular Therapeutix
OCUL
$2.25B
| $128K | ﹤0.01% |
24,893
-46,300
| -65% | -$275K |
|
|
FRBK
3414
DELISTED
Republic First Bancorp Inc
FRBK
| $128K | ﹤0.01% |
142,246
-163,400
| -53% | -$187K |
|
3415
Asia Pacific Wire & Cable
APWC
$65.6M
| $127K | ﹤0.01% |
72,700
+700
| +1% | +$1.13K |
|
3416
Pure Cycle
PCYO
$273M
| $127K | ﹤0.01% |
11,500
-83,900
| -88% | -$833K |
|
3417
Sight Sciences
SGHT
$456M
| $127K | ﹤0.01% |
+15,300
| New | +$138K |
|
3418
Fortress Biotech
FBIO
$91.4M
| $126K | ﹤0.01% |
15,228
-1,605
| -10% | -$15.9K |
|
|
ZFOX
3419
DELISTED
ZeroFox Holdings, Inc. Common Stock
ZFOX
| $126K | ﹤0.01% |
126,400
+66,476
| +111% | +$73.7K |
|
|
MTEM
3420
DELISTED
Molecular Templates, Inc.
MTEM
| $126K | ﹤0.01% |
17,555
+567
| +3% | +$3.88K |
|
3421
Cellectar Biosciences
CLRB
$20.8M
| $125K | ﹤0.01% |
2,133
+220
| +12% | +$10.6K |
|
3422
Delcath Systems
DCTH
$594M
| $125K | ﹤0.01% |
21,500
+9,400
| +78% | +$58.9K |
|
|
GHLD
3423
DELISTED
Guild Holdings
GHLD
| $125K | ﹤0.01% |
11,000
+700
| +7% | +$7.47K |
|
|
UPH
3424
DELISTED
UpHealth, Inc.
UPH
| $125K | ﹤0.01% |
66,456
+2,300
| +4% | +$3.81K |
|
|
AACG
3425
ATA Creativity
AACG
$39.3M
| $124K | ﹤0.01% |
86,644
-1,521
| -2% | -$2.48K |
|
Similar funds
Jim Simons's Q2 2023 Portfolio in Review
As of Q2 2023, Jim Simons held 4,468 positions worth $69.4B, down 7.9% from $75.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons withdrew a net $8.1B in Q2 2023, closing 599 positions and reducing 1,691 holdings. Its most notable exit was UnitedHealth, an estimated $686M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in Berkshire Hathaway Class A worth $316M.
- Jim Simons's largest Q2 2023 buy was Berkshire Hathaway Class A: 611 shares worth $316M.
- Jim Simons added most to Apple in Q2 2023, an estimated $856M increase.
- Jim Simons's biggest Q2 2023 reduction was Amazon, cutting an estimated $1.03B.
- Jim Simons fully exited UnitedHealth in Q2 2023, selling an estimated $686M.
- Jim Simons's ten largest holdings make up 12% of its $69.4B portfolio in Q2 2023.
- Jim Simons opened 541 new positions and closed 599 in Q2 2023.
- Jim Simons's portfolio value fell 7.9% quarter-over-quarter to $69.4B.
Based on Renaissance Technologies's 13F filing for Q2 2023, filed 11 Aug 2023.